| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Myocardial Infarction | 12 | 1991 | 129 |
Why?
|
Lead | 10 | 1995 | 55 |
Why?
|
Dust | 8 | 1995 | 22 |
Why?
|
Child Behavior | 3 | 1996 | 41 |
Why?
|
Air Pollution, Indoor | 4 | 1995 | 15 |
Why?
|
Parkinson Disease | 8 | 2001 | 67 |
Why?
|
Genetic Predisposition to Disease | 6 | 2005 | 132 |
Why?
|
Social Control, Informal | 1 | 2010 | 6 |
Why?
|
Male | 61 | 1991 | 1558 |
Why?
|
Female | 59 | 1991 | 1646 |
Why?
|
Internal-External Control | 1 | 2010 | 30 |
Why?
|
Coronary Artery Disease | 2 | 2005 | 56 |
Why?
|
Emotions | 1 | 2010 | 59 |
Why?
|
Suicide | 5 | 2002 | 60 |
Why?
|
Age of Onset | 3 | 1994 | 65 |
Why?
|
Middle Aged | 41 | 1991 | 1166 |
Why?
|
Aged | 36 | 1991 | 992 |
Why?
|
Heterozygote | 1 | 2008 | 80 |
Why?
|
Humans | 69 | 1988 | 1858 |
Why?
|
Environmental Exposure | 7 | 1996 | 75 |
Why?
|
African Continental Ancestry Group | 3 | 1996 | 80 |
Why?
|
Preventive Health Services | 2 | 1994 | 36 |
Why?
|
European Continental Ancestry Group | 3 | 1996 | 118 |
Why?
|
Body Temperature | 2 | 1999 | 44 |
Why?
|
Aggression | 1 | 2004 | 36 |
Why?
|
Neurodegenerative Diseases | 1 | 2002 | 30 |
Why?
|
Indans | 3 | 2006 | 12 |
Why?
|
Intubation, Gastrointestinal | 1 | 2001 | 9 |
Why?
|
Esophageal Perforation | 1 | 2001 | 10 |
Why?
|
Thermometers | 1 | 2001 | 5 |
Why?
|
Ear, Middle | 1 | 2001 | 11 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2001 | 21 |
Why?
|
Infant, Premature, Diseases | 1 | 2001 | 37 |
Why?
|
Research Design | 1 | 2002 | 169 |
Why?
|
Social Environment | 2 | 1992 | 58 |
Why?
|
Infant | 14 | 1988 | 464 |
Why?
|
Sperm Motility | 1 | 1999 | 9 |
Why?
|
Clinical Trials as Topic | 2 | 2002 | 251 |
Why?
|
New York | 8 | 1991 | 425 |
Why?
|
Urban Health | 2 | 1996 | 47 |
Why?
|
Family Practice | 2 | 1994 | 84 |
Why?
|
Seasons | 1 | 1999 | 64 |
Why?
|
Diltiazem | 3 | 1991 | 15 |
Why?
|
Cross-Sectional Studies | 9 | 1995 | 254 |
Why?
|
Management Information Systems | 1 | 1999 | 3 |
Why?
|
Disabled Children | 1 | 1999 | 11 |
Why?
|
Research Support as Topic | 1 | 1999 | 27 |
Why?
|
Prospective Studies | 15 | 1991 | 547 |
Why?
|
Constipation | 1 | 1998 | 5 |
Why?
|
Gastrointestinal Agents | 1 | 1998 | 11 |
Why?
|
Colchicine | 1 | 1998 | 22 |
Why?
|
Aging | 2 | 1999 | 275 |
Why?
|
Urban Population | 4 | 1995 | 81 |
Why?
|
Disabled Persons | 1 | 1998 | 35 |
Why?
|
Cohort Studies | 7 | 1991 | 333 |
Why?
|
Multivariate Analysis | 8 | 1991 | 227 |
Why?
|
Health Services Needs and Demand | 1 | 1999 | 66 |
Why?
|
Managed Care Programs | 1 | 1999 | 50 |
Why?
|
Huntington Disease | 2 | 2008 | 30 |
Why?
|
Risk Factors | 15 | 1992 | 557 |
Why?
|
Developmental Disabilities | 1 | 1998 | 54 |
Why?
|
Reminder Systems | 2 | 1994 | 16 |
Why?
|
Interpersonal Relations | 2 | 1992 | 74 |
Why?
|
Child, Preschool | 11 | 1995 | 555 |
Why?
|
Regression Analysis | 5 | 1996 | 256 |
Why?
|
Follow-Up Studies | 14 | 1991 | 554 |
Why?
|
Lead Poisoning | 4 | 1998 | 32 |
Why?
|
Monoamine Oxidase Inhibitors | 2 | 2006 | 16 |
Why?
|
Child | 8 | 1995 | 750 |
Why?
|
Breast Feeding | 3 | 1999 | 45 |
Why?
|
Double-Blind Method | 8 | 1991 | 274 |
Why?
|
Polymorphism, Genetic | 2 | 2006 | 94 |
Why?
|
Retrospective Studies | 10 | 1991 | 656 |
Why?
|
Genotype | 5 | 2002 | 175 |
Why?
|
Lipids | 2 | 1994 | 98 |
Why?
|
Hypertension | 3 | 1991 | 161 |
Why?
|
Survival Analysis | 6 | 1992 | 206 |
Why?
|
Severity of Illness Index | 7 | 1993 | 359 |
Why?
|
Stroke Volume | 2 | 1992 | 54 |
Why?
|
Health Status | 2 | 2004 | 127 |
Why?
|
Ambulatory Care Information Systems | 1 | 1994 | 5 |
Why?
|
Proportional Hazards Models | 7 | 1992 | 123 |
Why?
|
Infant, Newborn | 7 | 1988 | 389 |
Why?
|
Adult | 19 | 1991 | 1321 |
Why?
|
Prognosis | 10 | 1991 | 389 |
Why?
|
Aged, 80 and over | 11 | 2002 | 602 |
Why?
|
Quality of Life | 3 | 1997 | 188 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2001 | 33 |
Why?
|
Primary Health Care | 4 | 2002 | 151 |
Why?
|
Agricultural Workers' Diseases | 2 | 2000 | 3 |
Why?
|
Biological Markers | 3 | 2009 | 263 |
Why?
|
Cocaine | 2 | 2001 | 33 |
Why?
|
Single Person | 1 | 1992 | 8 |
Why?
|
Stress, Psychological | 2 | 2004 | 118 |
Why?
|
Incidence | 3 | 1992 | 337 |
Why?
|
Bronchial Spasm | 1 | 1991 | 11 |
Why?
|
Ventricular Function, Left | 1 | 1992 | 41 |
Why?
|
Lung Diseases, Obstructive | 1 | 1991 | 30 |
Why?
|
Immunization Programs | 1 | 2011 | 24 |
Why?
|
Resilience, Psychological | 1 | 2010 | 7 |
Why?
|
Schools | 1 | 2010 | 28 |
Why?
|
Depression | 2 | 2004 | 119 |
Why?
|
Death, Sudden, Cardiac | 1 | 1992 | 31 |
Why?
|
Tocopherols | 1 | 2009 | 9 |
Why?
|
Metal Nanoparticles | 1 | 2010 | 10 |
Why?
|
Toxicity Tests | 1 | 2010 | 17 |
Why?
|
Fever | 2 | 1999 | 66 |
Why?
|
Length of Stay | 1 | 1991 | 168 |
Why?
|
Social Behavior | 1 | 2010 | 53 |
Why?
|
Food Habits | 1 | 2009 | 15 |
Why?
|
Selegiline | 1 | 2009 | 16 |
Why?
|
Uric Acid | 1 | 2009 | 25 |
Why?
|
Eating | 1 | 2009 | 37 |
Why?
|
Recurrence | 7 | 1992 | 261 |
Why?
|
Hodgkin Disease | 3 | 1993 | 46 |
Why?
|
Weight Loss | 1 | 2009 | 52 |
Why?
|
Time Factors | 7 | 1988 | 896 |
Why?
|
Pulmonary Valve | 1 | 1988 | 11 |
Why?
|
Tetralogy of Fallot | 1 | 1988 | 12 |
Why?
|
Tetrabenazine | 1 | 2008 | 3 |
Why?
|
Tricuspid Valve | 1 | 1988 | 16 |
Why?
|
Chorea | 1 | 2008 | 5 |
Why?
|
Mental Disorders | 2 | 2004 | 132 |
Why?
|
Influenza Vaccines | 1 | 2011 | 70 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2008 | 14 |
Why?
|
Age Factors | 7 | 1995 | 480 |
Why?
|
Subclavian Artery | 1 | 1988 | 22 |
Why?
|
Body Mass Index | 1 | 2009 | 122 |
Why?
|
Questionnaires | 4 | 2004 | 361 |
Why?
|
Withholding Treatment | 1 | 2008 | 23 |
Why?
|
Smoking | 2 | 1994 | 153 |
Why?
|
Sex Distribution | 1 | 2008 | 101 |
Why?
|
Antioxidants | 1 | 2009 | 84 |
Why?
|
Pulmonary Artery | 1 | 1988 | 58 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 1997 | 23 |
Why?
|
Heart Defects, Congenital | 1 | 1988 | 55 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2007 | 9 |
Why?
|
Age Distribution | 1 | 2008 | 127 |
Why?
|
Disease Progression | 3 | 2001 | 244 |
Why?
|
Influenza, Human | 1 | 2011 | 94 |
Why?
|
Aryldialkylphosphatase | 1 | 2007 | 6 |
Why?
|
Vehicle Emissions | 1 | 2007 | 14 |
Why?
|
Chi-Square Distribution | 3 | 1994 | 179 |
Why?
|
Angiotensinogen | 1 | 2006 | 8 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 40 |
Why?
|
Autonomic Nervous System | 1 | 2007 | 41 |
Why?
|
Behavioral Symptoms | 1 | 2006 | 10 |
Why?
|
Hypotension, Orthostatic | 1 | 2006 | 10 |
Why?
|
Palliative Care | 1 | 1988 | 65 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2007 | 32 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2006 | 7 |
Why?
|
Sex Factors | 4 | 1992 | 286 |
Why?
|
Confusion | 1 | 2006 | 6 |
Why?
|
Risk Assessment | 2 | 2005 | 325 |
Why?
|
Analysis of Variance | 4 | 1997 | 339 |
Why?
|
Colic | 1 | 2006 | 5 |
Why?
|
Crying | 1 | 2006 | 7 |
Why?
|
Killer Cells, Natural | 1 | 2007 | 62 |
Why?
|
Infant Behavior | 1 | 2006 | 8 |
Why?
|
Parent-Child Relations | 1 | 2007 | 53 |
Why?
|
Inhalation Exposure | 1 | 2007 | 22 |
Why?
|
Expressed Emotion | 1 | 2005 | 5 |
Why?
|
Stem Cell Transplantation | 2 | 1993 | 50 |
Why?
|
Angina, Unstable | 1 | 2005 | 20 |
Why?
|
Social Perception | 1 | 2005 | 28 |
Why?
|
Antiparkinson Agents | 1 | 2006 | 23 |
Why?
|
Reproducibility of Results | 3 | 1995 | 392 |
Why?
|
Reference Values | 3 | 1999 | 281 |
Why?
|
Occupational Exposure | 2 | 2000 | 53 |
Why?
|
Cerebrovascular Disorders | 1 | 2006 | 66 |
Why?
|
Lung | 1 | 1992 | 233 |
Why?
|
Neuroprotective Agents | 1 | 2006 | 60 |
Why?
|
Cost of Illness | 1 | 2005 | 54 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2005 | 24 |
Why?
|
Family | 2 | 1996 | 102 |
Why?
|
Mothers | 1 | 2006 | 47 |
Why?
|
Social Identification | 1 | 2004 | 11 |
Why?
|
Cognition | 1 | 2006 | 98 |
Why?
|
Lung Neoplasms | 2 | 1997 | 160 |
Why?
|
Caregivers | 1 | 2005 | 50 |
Why?
|
Hearing Loss, High-Frequency | 1 | 2004 | 1 |
Why?
|
Arterial Occlusive Diseases | 1 | 2005 | 36 |
Why?
|
Blood Pressure | 1 | 2007 | 205 |
Why?
|
Femoral Artery | 1 | 2005 | 52 |
Why?
|
Air Pollutants | 1 | 2007 | 42 |
Why?
|
Pesticides | 1 | 2004 | 10 |
Why?
|
Social Adjustment | 1 | 2004 | 38 |
Why?
|
Catchment Area (Health) | 1 | 2004 | 16 |
Why?
|
Parkinsonian Disorders | 1 | 2004 | 19 |
Why?
|
Case-Control Studies | 4 | 2004 | 284 |
Why?
|
Angioplasty, Balloon | 1 | 2005 | 35 |
Why?
|
Arteriosclerosis | 1 | 2005 | 54 |
Why?
|
Depressive Disorder, Major | 1 | 2006 | 37 |
Why?
|
Bone Marrow Transplantation | 2 | 1995 | 90 |
Why?
|
Self-Assessment | 1 | 2004 | 35 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 1995 | 42 |
Why?
|
Activities of Daily Living | 1 | 2005 | 122 |
Why?
|
Treatment Outcome | 5 | 1993 | 662 |
Why?
|
Pacifiers | 1 | 2003 | 5 |
Why?
|
Housing | 3 | 1996 | 19 |
Why?
|
Patient Discharge | 2 | 1992 | 61 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2003 | 17 |
Why?
|
Bottle Feeding | 1 | 2003 | 12 |
Why?
|
Life Change Events | 1 | 2004 | 51 |
Why?
|
Cognition Disorders | 1 | 2006 | 108 |
Why?
|
Chronic Disease | 2 | 1991 | 270 |
Why?
|
Data Interpretation, Statistical | 2 | 1997 | 110 |
Why?
|
Firearms | 1 | 2002 | 10 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 127 |
Why?
|
Colonic Neoplasms | 1 | 2003 | 63 |
Why?
|
Predictive Value of Tests | 4 | 1993 | 322 |
Why?
|
Receptor, Epidermal Growth Factor | 1 | 2003 | 54 |
Why?
|
Hemochromatosis | 1 | 2002 | 8 |
Why?
|
Iatrogenic Disease | 1 | 2001 | 30 |
Why?
|
Depressive Disorder | 1 | 2005 | 77 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 32 |
Why?
|
Mutation, Missense | 1 | 2002 | 59 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 94 |
Why?
|
Socioeconomic Factors | 3 | 2004 | 145 |
Why?
|
Housekeeping | 1 | 2000 | 1 |
Why?
|
Noise, Occupational | 1 | 2000 | 2 |
Why?
|
Antigens, CD | 1 | 2003 | 128 |
Why?
|
Hearing Disorders | 1 | 2000 | 21 |
Why?
|
Models, Statistical | 1 | 2002 | 114 |
Why?
|
Sensitivity and Specificity | 2 | 1999 | 427 |
Why?
|
Neuropsychological Tests | 3 | 2006 | 114 |
Why?
|
Soil | 2 | 1996 | 3 |
Why?
|
Sperm Count | 1 | 1999 | 10 |
Why?
|
Motion | 1 | 1999 | 23 |
Why?
|
Parenteral Nutrition | 1 | 1999 | 21 |
Why?
|
Stomatitis | 1 | 1999 | 10 |
Why?
|
Infant, Premature | 1 | 2001 | 70 |
Why?
|
Child, Hospitalized | 1 | 1999 | 12 |
Why?
|
Disability Evaluation | 2 | 2009 | 61 |
Why?
|
Leukocyte Count | 1 | 1999 | 94 |
Why?
|
Mouth Mucosa | 1 | 1999 | 28 |
Why?
|
Fee-for-Service Plans | 1 | 1999 | 10 |
Why?
|
Alzheimer Disease | 1 | 2002 | 72 |
Why?
|
Infant Care | 1 | 1999 | 17 |
Why?
|
Social Isolation | 2 | 1992 | 18 |
Why?
|
Rural Population | 1 | 1999 | 30 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 128 |
Why?
|
Soil Pollutants | 1 | 1998 | 1 |
Why?
|
Cross-Over Studies | 1 | 1998 | 82 |
Why?
|
Membrane Glycoproteins | 1 | 2001 | 154 |
Why?
|
Water Supply | 1 | 1998 | 14 |
Why?
|
Survival Rate | 3 | 1994 | 250 |
Why?
|
Adolescent | 4 | 1995 | 892 |
Why?
|
Health Behavior | 1 | 1999 | 62 |
Why?
|
Leukemia | 1 | 1999 | 70 |
Why?
|
Membrane Proteins | 1 | 2002 | 233 |
Why?
|
Quality Assurance, Health Care | 1 | 1999 | 83 |
Why?
|
United States | 4 | 1994 | 604 |
Why?
|
Genetic Testing | 2 | 2005 | 49 |
Why?
|
Likelihood Functions | 1 | 1997 | 43 |
Why?
|
Sample Size | 1 | 1997 | 24 |
Why?
|
Patient Satisfaction | 1 | 1999 | 120 |
Why?
|
Quality of Health Care | 1 | 1999 | 85 |
Why?
|
Mortality | 1 | 1997 | 50 |
Why?
|
Social Support | 2 | 1992 | 111 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 1998 | 49 |
Why?
|
DNA Mutational Analysis | 2 | 2002 | 110 |
Why?
|
Levodopa | 2 | 2006 | 28 |
Why?
|
Logistic Models | 3 | 1999 | 254 |
Why?
|
Pulmonary Edema | 2 | 1991 | 25 |
Why?
|
Sucking Behavior | 2 | 2003 | 9 |
Why?
|
Toxicology | 1 | 1995 | 26 |
Why?
|
Computer Systems | 1 | 1994 | 13 |
Why?
|
Gene Frequency | 2 | 2002 | 42 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 431 |
Why?
|
Statistics as Topic | 2 | 2004 | 133 |
Why?
|
Psychiatric Status Rating Scales | 2 | 1999 | 100 |
Why?
|
Demography | 1 | 1994 | 87 |
Why?
|
Pediatrics | 1 | 1999 | 133 |
Why?
|
Antineoplastic Agents | 1 | 1999 | 191 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 1993 | 121 |
Why?
|
Digitalis Glycosides | 1 | 1992 | 6 |
Why?
|
Patient Compliance | 1 | 1994 | 114 |
Why?
|
Radionuclide Ventriculography | 1 | 1992 | 4 |
Why?
|
Transplantation, Autologous | 3 | 1995 | 79 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1992 | 36 |
Why?
|
Lymphoma | 1 | 1993 | 96 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1992 | 47 |
Why?
|
Cause of Death | 1 | 1992 | 82 |
Why?
|
Probability | 2 | 2000 | 190 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1991 | 17 |
Why?
|
Diagnosis-Related Groups | 1 | 1991 | 21 |
Why?
|
Treatment Refusal | 1 | 2011 | 31 |
Why?
|
Clinical Protocols | 1 | 1991 | 93 |
Why?
|
Arrhythmias, Cardiac | 1 | 1992 | 66 |
Why?
|
Glucuronidase | 1 | 2010 | 26 |
Why?
|
Rats | 2 | 2007 | 532 |
Why?
|
Gold | 1 | 2010 | 17 |
Why?
|
Copper | 1 | 2010 | 36 |
Why?
|
Dietary Proteins | 1 | 2009 | 26 |
Why?
|
Luciferases | 1 | 2010 | 70 |
Why?
|
Dietary Carbohydrates | 1 | 2009 | 23 |
Why?
|
Energy Intake | 1 | 2009 | 38 |
Why?
|
Continental Population Groups | 2 | 1998 | 85 |
Why?
|
Community Health Services | 1 | 2010 | 60 |
Why?
|
Dietary Fats | 1 | 2009 | 33 |
Why?
|
Macrophages, Alveolar | 1 | 2010 | 44 |
Why?
|
Feasibility Studies | 1 | 2009 | 144 |
Why?
|
Rats, Inbred F344 | 1 | 2010 | 80 |
Why?
|
Titanium | 1 | 2010 | 37 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2009 | 21 |
Why?
|
Energy Metabolism | 1 | 2009 | 80 |
Why?
|
Sutures | 1 | 1988 | 18 |
Why?
|
Movement | 1 | 2009 | 69 |
Why?
|
Anastomosis, Surgical | 1 | 1988 | 45 |
Why?
|
Longitudinal Studies | 1 | 2009 | 195 |
Why?
|
Suture Techniques | 1 | 1988 | 50 |
Why?
|
Patient Selection | 1 | 2009 | 156 |
Why?
|
Reoperation | 1 | 1988 | 106 |
Why?
|
Epidemiology | 1 | 2007 | 15 |
Why?
|
Reactive Oxygen Species | 1 | 2010 | 112 |
Why?
|
Rats, Inbred SHR | 1 | 2007 | 24 |
Why?
|
Injections, Intraperitoneal | 1 | 2007 | 57 |
Why?
|
Automobile Driving | 1 | 2007 | 19 |
Why?
|
Aspartic Acid | 1 | 2007 | 37 |
Why?
|
Telemetry | 1 | 2007 | 19 |
Why?
|
Glutamine | 1 | 2007 | 27 |
Why?
|
Threonine | 1 | 2006 | 27 |
Why?
|
Aerosols | 1 | 2007 | 39 |
Why?
|
Methionine | 1 | 2006 | 38 |
Why?
|
Administration, Inhalation | 1 | 2007 | 60 |
Why?
|
Hallucinations | 1 | 2006 | 12 |
Why?
|
Homozygote | 1 | 2006 | 68 |
Why?
|
Arginine | 1 | 2007 | 57 |
Why?
|
Dopamine Agents | 1 | 2006 | 19 |
Why?
|
Rats, Sprague-Dawley | 1 | 2010 | 257 |
Why?
|
Glutamic Acid | 1 | 2007 | 66 |
Why?
|
Particle Size | 1 | 2007 | 55 |
Why?
|
Disease-Free Survival | 2 | 1995 | 102 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 34 |
Why?
|
Dopamine Agonists | 1 | 2006 | 14 |
Why?
|
Child Welfare | 2 | 1996 | 41 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 98 |
Why?
|
Family Relations | 1 | 2005 | 28 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 70 |
Why?
|
Vascular Patency | 1 | 2005 | 28 |
Why?
|
Religion and Psychology | 1 | 2004 | 12 |
Why?
|
Area Under Curve | 1 | 2004 | 48 |
Why?
|
Personality Assessment | 1 | 2004 | 30 |
Why?
|
Combined Modality Therapy | 2 | 1993 | 219 |
Why?
|
Heart Rate | 1 | 2007 | 138 |
Why?
|
Iodine Radioisotopes | 1 | 2004 | 64 |
Why?
|
Geriatric Assessment | 1 | 2005 | 63 |
Why?
|
DNA | 1 | 2009 | 263 |
Why?
|
Sick Role | 1 | 2004 | 26 |
Why?
|
Employment | 1 | 2004 | 47 |
Why?
|
Family Health | 1 | 2004 | 69 |
Why?
|
Infant Equipment | 1 | 2003 | 5 |
Why?
|
Feeding Methods | 1 | 2003 | 5 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 176 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2003 | 14 |
Why?
|
Interviews as Topic | 1 | 2004 | 95 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2003 | 13 |
Why?
|
Birth Weight | 1 | 2003 | 50 |
Why?
|
Inflammation | 1 | 2007 | 208 |
Why?
|
Australia | 1 | 2002 | 27 |
Why?
|
Ferritins | 1 | 2002 | 36 |
Why?
|
Substance-Related Disorders | 1 | 2004 | 96 |
Why?
|
Putamen | 1 | 2001 | 10 |
Why?
|
Caudate Nucleus | 1 | 2001 | 14 |
Why?
|
Liver Cirrhosis | 1 | 2002 | 48 |
Why?
|
Stents | 1 | 2005 | 55 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2001 | 17 |
Why?
|
Dominance, Cerebral | 1 | 2001 | 34 |
Why?
|
Electrocardiography | 1 | 2007 | 133 |
Why?
|
Residence Characteristics | 1 | 2002 | 39 |
Why?
|
Neurologic Examination | 1 | 2001 | 64 |
Why?
|
Brain | 1 | 2009 | 305 |
Why?
|
Membrane Transport Proteins | 1 | 2001 | 43 |
Why?
|
Animals | 2 | 2007 | 1032 |
Why?
|
Heart Diseases | 1 | 2002 | 92 |
Why?
|
Outcome Assessment (Health Care) | 1 | 2004 | 164 |
Why?
|
Audiometry | 1 | 2000 | 11 |
Why?
|
Child Development | 1 | 2003 | 49 |
Why?
|
Corpus Striatum | 1 | 2001 | 48 |
Why?
|
Prevalence | 1 | 2002 | 282 |
Why?
|
Ear | 1 | 1999 | 8 |
Why?
|
Diarrhea | 1 | 1999 | 41 |
Why?
|
Health Surveys | 1 | 2000 | 104 |
Why?
|
Rectum | 1 | 1999 | 29 |
Why?
|
Single-Blind Method | 1 | 1999 | 86 |
Why?
|
Databases, Factual | 1 | 1999 | 103 |
Why?
|
Carmustine | 1 | 1998 | 25 |
Why?
|
Primary Prevention | 1 | 1999 | 44 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1998 | 49 |
Why?
|
Etoposide | 1 | 1998 | 37 |
Why?
|
Cytarabine | 1 | 1998 | 32 |
Why?
|
Cyclophosphamide | 1 | 1998 | 84 |
Why?
|
Neoplasm, Residual | 1 | 1997 | 19 |
Why?
|
Pregnancy | 1 | 2003 | 457 |
Why?
|
Water | 1 | 1996 | 85 |
Why?
|
Pain | 1 | 1999 | 192 |
Why?
|
African Americans | 1 | 1996 | 108 |
Why?
|
Actuarial Analysis | 1 | 1993 | 21 |
Why?
|
Transplantation, Homologous | 1 | 1995 | 94 |
Why?
|
Smoking Cessation | 1 | 1994 | 46 |
Why?
|
Hemodynamics | 1 | 1991 | 131 |
Why?
|
